Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	decreased corpus callosum size	ANK2 CLIP2 MYCBP2 AFF3 SHTN1 THOC2 ULK4	5.60e-09	47	76	7	MP:0000781
MousePheno	abnormal corpus callosum size	ANK2 CLIP2 MYCBP2 AFF3 SHTN1 THOC2 ULK4	1.16e-08	52	76	7	MP:0020573
MousePheno	abnormal corpus callosum morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 SHTN1 THOC2 ULK4 MARCKS	3.10e-08	129	76	9	MP:0000780
MousePheno	abnormal dorsal telencephalic commissure morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 SHTN1 THOC2 ULK4 MARCKS	3.79e-08	132	76	9	MP:0008219
MousePheno	abnormal brain commissure morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 SHTN1 THOC2 ULK4 MARCKS	2.10e-07	161	76	9	MP:0002199
MousePheno	abnormal nervous system tract morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 SHTN1 THOC2 ULK4 MARCKS	8.15e-07	189	76	9	MP:0000778
MousePheno	abnormal brain white matter morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 SHTN1 THOC2 ULK4 MARCKS	1.67e-06	206	76	9	MP:0008026
MousePheno	abnormal brain ventricle morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 ATXN1 TET1 ULK4 MARCKS	2.38e-05	286	76	9	MP:0000822
MousePheno	dilated brain ventricle	CLIP2 MYCBP2 ATXN1 ULK4 MARCKS	1.41e-04	92	76	5	MP:0012676
MousePheno	abnormal classified tumor incidence	CYLD SMG1 ASXL1 PRDM2 PTPRZ1 TET1 PAK1 KMT2A TP53BP1	2.27e-04	384	76	9	MP:0020188
MousePheno	abnormal brain ventricular system morphology	ANK2 CLIP2 MYCBP2 AFF3 MARCKSL1 ATXN1 TET1 ULK4 MARCKS	2.70e-04	393	76	9	MP:0002200
Domain	CCDC74_C	CCDC74B CCDC74A	2.78e-05	2	99	2	PF14917
Domain	CCDC74	CCDC74B CCDC74A	2.78e-05	2	99	2	IPR033226
Domain	MARCKS_1	MARCKSL1 MARCKS	2.78e-05	2	99	2	PS00826
Domain	MARCKS_2	MARCKSL1 MARCKS	2.78e-05	2	99	2	PS00827
Domain	CCDC74_C	CCDC74B CCDC74A	2.78e-05	2	99	2	IPR029422
Domain	MARCKS	MARCKSL1 MARCKS	2.78e-05	2	99	2	IPR002101
Domain	MARCKS	MARCKSL1 MARCKS	2.78e-05	2	99	2	PF02063
Domain	zf-C2H2_6	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZNF600 ZNF611 ZNF808 ZNF701	4.40e-05	314	99	9	PF13912
Domain	TF_AF4/FMR2	AFF3 AFF4	1.66e-04	4	99	2	IPR007797
Domain	AF-4	AFF3 AFF4	1.66e-04	4	99	2	PF05110
Domain	Znf_C2H2-like	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZC3H7A ZNF600 ZNF611 ZNF638 ZNF808 ZNF701 ZNF292	1.02e-03	796	99	12	IPR015880
Domain	Znf_C2H2	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZC3H7A ZNF600 ZNF611 ZNF638 ZNF808 ZNF701 ZNF292	1.12e-03	805	99	12	IPR007087
Domain	ZnF_C2H2	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZC3H7A ZNF600 ZNF611 ZNF638 ZNF808 ZNF701 ZNF292	1.16e-03	808	99	12	SM00355
Domain	CAP_GLY	CYLD CLIP2	1.22e-03	10	99	2	PF01302
Domain	CAP_GLY_1	CYLD CLIP2	1.22e-03	10	99	2	PS00845
Domain	CAP_GLY_2	CYLD CLIP2	1.22e-03	10	99	2	PS50245
Domain	CAP-Gly_domain	CYLD CLIP2	1.22e-03	10	99	2	IPR000938
Domain	CAP_GLY	CYLD CLIP2	1.22e-03	10	99	2	SM01052
Domain	-	CYLD CLIP2	1.22e-03	10	99	2	2.30.30.190
Domain	Znf_CXXC	TET1 KMT2A	1.48e-03	11	99	2	IPR002857
Domain	ZF_CXXC	TET1 KMT2A	1.48e-03	11	99	2	PS51058
Domain	zf-CXXC	TET1 KMT2A	1.48e-03	11	99	2	PF02008
Domain	ZINC_FINGER_C2H2_2	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZC3H7A ZNF600 ZNF611 ZNF808 ZNF701 ZNF292	2.66e-03	775	99	11	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZC3H7A ZNF600 ZNF611 ZNF808 ZNF701 ZNF292	2.71e-03	777	99	11	PS00028
Domain	KRAB	ZNF845 ZNF321P ZNF813 ZNF8 ZNF611 ZNF808 ZNF701	2.95e-03	358	99	7	PS50805
Domain	KRAB	ZNF845 ZNF321P ZNF813 ZNF8 ZNF611 ZNF808 ZNF701	2.95e-03	358	99	7	PF01352
Domain	-	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZNF600 ZNF611 ZNF808 ZNF701 ZNF292	3.21e-03	679	99	10	3.30.160.60
Domain	KRAB	ZNF845 ZNF321P ZNF813 ZNF8 ZNF611 ZNF808 ZNF701	3.49e-03	369	99	7	SM00349
Domain	KRAB	ZNF845 ZNF321P ZNF813 ZNF8 ZNF611 ZNF808 ZNF701	3.54e-03	370	99	7	IPR001909
Domain	zf-C2H2	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZNF600 ZNF611 ZNF808 ZNF701 ZNF292	3.70e-03	693	99	10	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF845 ZNF391 ZNF813 PRDM2 ZNF8 ZNF600 ZNF611 ZNF808 ZNF701 ZNF292	3.74e-03	694	99	10	IPR013087
Domain	Ank_2	ANKRD31 ANK2 BCORL1 ASB15 ANKRD33B	5.75e-03	215	99	5	PF12796
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD SMG1 ASXL1 CLIP2 MYCBP2 SIPA1L3 PSD3 TNRC6C ADCY9 GPR158 CEP72	9.51e-11	225	105	11	12168954
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CCDC14 CYLD MYCBP2 PARP2 BCORL1 NCBP1 SHTN1 THOC2 ZNF8 CEP72 ZNF638 NAV1 KMT2A KDM1B	9.64e-09	645	105	14	25281560
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ABCC3 ABI1 ANK2 TMEM199 PSD3 MARCKSL1 ADCY9 GPR158 BSG MICAL2 NAV1 DCUN1D3 MARCKS	1.86e-08	569	105	13	30639242
Pubmed	Human transcription factor protein interaction networks.	CYLD SMG1 ASXL1 BCORL1 MAML1 CEP192 TNRC6C NKRF PRDM2 ATXN1 BSG TLE3 ZNF611 ZNF638 KMT2A KDM1B RBM34 TP53BP1 RAVER1	5.16e-08	1429	105	19	35140242
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SMG1 ABCC3 NYAP2 WDR64 BCORL1 MAML1 NBEA DSN1 CEP72 TLE3 HFM1 RBM34 RAVER1	7.04e-08	638	105	13	31182584
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	AFF3 CCNT1 KMT2A AFF4	7.67e-08	14	105	4	20854876
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TIGAR MYCBP2 SIPA1L3 AFF3 PTDSS1 SRCIN1 CEP192 TNRC6C SHTN1 TASOR2 ATXN1 GPR158 MICAL2 TLE3 ZNF638 NAV1 CSMD1 AFF4 RAVER1	9.80e-08	1489	105	19	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	USP36 ABI1 SIPA1L3 PARP2 PTDSS1 MAML1 SRPK1 ABCF2 MARCKSL1 CGGBP1 N4BP3 NKRF JARID2 CCNT1 ZC3H7A KMT2A KDM1B MARCKS AFF4	1.06e-07	1497	105	19	31527615
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD ABI1 NYAP2 ANK2 CLIP2 MYCBP2 SIPA1L3 NBEA SHTN1 CCDC13 GPR158 PAK1 NAV1 AFF4 TP53BP1	2.12e-07	963	105	15	28671696
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF845 BCORL1 ZNF813 NCBP1 PRDM2 ZNF8 CCNT1 KMT2A KDM1B AFF4 RBM34 ZNF292	3.26e-07	608	105	12	36089195
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD ABI1 SASH1 MYCBP2 KIF26B SIPA1L3 PSD3 CEP192 N4BP3 SHTN1 ATXN1 TET1 NAV1 KMT2A	3.34e-07	861	105	14	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CCDC14 USP36 MYCBP2 SIPA1L3 PSD3 NCBP1 NBEA CEP192 ADCY9 CEP72 BSG PTPRZ1 TLE3 ZNF638 RAVER1	6.23e-07	1049	105	15	27880917
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	NBEA CEP192 TNRC6C SHTN1 TLE3 CADPS2	6.58e-07	101	105	6	10997877
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ABI1 ANK2 CLIP2 MYCBP2 NBEA SRCIN1 ADCY9 PAK1 MARCKS	1.14e-06	347	105	9	17114649
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	USP36 SMG1 PARP2 DSN1 CCNT1 NAV1 KMT2A	1.63e-06	186	105	7	33637726
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD ABI1 NYAP2 FRMPD4 ANK2 MYCBP2 PSD3 NBEA MARCKSL1 SRCIN1 GPR158 BSG NAV1 MARCKS TP53BP1	1.73e-06	1139	105	15	36417873
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CYLD TIGAR TBC1D15 ANK2 MYCBP2 TMEM199 PTDSS1 PSD3 SRPK1 MARCKSL1 CEP192 ADCY9 ZC3H7A BSG MARCKS RBM34 TP53BP1	2.26e-06	1487	105	17	33957083
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	SASH1 KIF26B TMEM199 PSD3 MARCKSL1 ADCY9 BSG DCUN1D3 MARCKS	2.26e-06	377	105	9	38117590
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	ASXL1 MYCBP2 BCORL1 DSN1 JARID2 CEP72 TET1 KMT2A KDM1B ZNF292	2.69e-06	495	105	10	27705803
Pubmed	A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.	CCNT1 KMT2A AFF4	3.16e-06	10	105	3	20153263
Pubmed	CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.	CCNT1 KMT2A AFF4	3.16e-06	10	105	3	22094252
Pubmed	Widespread neuronal ectopia associated with secondary defects in cerebrocortical chondroitin sulfate proteoglycans and basal lamina in MARCKS-deficient mice.	MARCKSL1 PTPRZ1 MARCKS	3.16e-06	10	105	3	9184108
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD ASXL1 FRMPD4 TRO PSD3 CEP192 TNRC6C TLE3 NAV1	4.21e-06	407	105	9	12693553
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TBC1D15 MYCBP2 BCORL1 SHTN1 PRDM2 ZNF8 TLE3 TET1 NAV1	5.22e-06	418	105	9	34709266
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	USP36 AFF3 MAML1 NKRF CCNT1 POLQ AFF4	5.26e-06	222	105	7	37071664
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	SIPA1L3 PARP2 SRPK1 ABCF2 NCBP1 THOC2 NKRF PPL TASOR2 BSG ZNF638 NAV1 MARCKS RBM34 RAVER1	5.71e-06	1257	105	15	36526897
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 ANK2 TRO SIPA1L3 BIVM ABCF2 NCBP1 PPL TASOR2 ZC3H7A BSG KMT2A CADPS2 POLQ CCDC191 ZNF292	6.77e-06	1442	105	16	35575683
Pubmed	Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.	TET1 KMT2A	9.03e-06	2	105	2	23100278
Pubmed	Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23).	AFF3 KMT2A	9.03e-06	2	105	2	12743608
Pubmed	LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).	TET1 KMT2A	9.03e-06	2	105	2	12124344
Pubmed	LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia.	AFF3 KMT2A	9.03e-06	2	105	2	12203795
Pubmed	Suppression of the lipopolysaccharide-induced expression of MARCKS-related protein (MRP) affects transmigration in activated RAW264.7 cells.	MARCKSL1 MARCKS	9.03e-06	2	105	2	19246034
Pubmed	Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability.	JARID2 ATXN1	9.03e-06	2	105	2	23294540
Pubmed	The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.	TET1 KMT2A	9.03e-06	2	105	2	19144982
Pubmed	ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).	ABI1 KMT2A	9.03e-06	2	105	2	9694699
Pubmed	First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.	TET1 KMT2A	9.03e-06	2	105	2	24323992
Pubmed	A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis.	MARCKSL1 MARCKS	9.03e-06	2	105	2	19924305
Pubmed	The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat.	CCNT1 AFF4	9.03e-06	2	105	2	23471103
Pubmed	MacMARCKS, a novel member of the MARCKS family of protein kinase C substrates.	MARCKSL1 MARCKS	9.03e-06	2	105	2	1516135
Pubmed	The regulation of MacMARCKS expression by integrin beta3.	MARCKSL1 MARCKS	9.03e-06	2	105	2	17292354
Pubmed	MARCKS deficiency in mice leads to abnormal brain development and perinatal death.	MARCKSL1 MARCKS	9.03e-06	2	105	2	7862670
Pubmed	Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex.	CCNT1 AFF4	9.03e-06	2	105	2	27731797
Pubmed	jumonji gene maps to mouse chromosome 13.	JARID2 ATXN1	9.03e-06	2	105	2	9339385
Pubmed	Is t(10;11)(p11.2;q23) involving MLL and ABI-1 genes associated with congenital acute monocytic leukemia?	ABI1 KMT2A	9.03e-06	2	105	2	12547160
Pubmed	CCDC74A/B are K-fiber crosslinkers required for chromosomal alignment.	CCDC74B CCDC74A	9.03e-06	2	105	2	31521166
Pubmed	Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes.	CGGBP1 SHTN1 ZNF8 TLE3 ZNF638 TP53BP1	1.14e-05	165	105	6	16107646
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	CCDC14 CYLD MYCBP2 CEP192 CEP72	1.43e-05	101	105	5	24613305
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MAML1 CCNT1 ATXN1 TLE3 KMT2A AFF4 RAVER1	1.78e-05	268	105	7	33640491
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	USP36 ANK2 THOC2 TASOR2 CCNT1 ZNF638 TP53BP1	1.92e-05	271	105	7	32433965
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CCDC14 SIPA1L3 CEP192 ATXN1 NAV1 RAVER1	2.11e-05	184	105	6	32908313
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	SIPA1L3 SRPK1 ABCF2 NCBP1 MARCKSL1 THOC2 NKRF CCNT1 BSG MICAL2 PAK1 DCUN1D3 AFF4 RAVER1	2.37e-05	1247	105	14	27684187
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP36 CYLD MAML1 NBEA MARCKSL1 CEP192 ADCY9 PPL TASOR2 ZNF638 MARCKS	2.39e-05	777	105	11	35844135
Pubmed	MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth and invasion.	PTPRZ1 PAK1	2.70e-05	3	105	2	31364003
Pubmed	MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein.	CCNT1 AFF4	2.70e-05	3	105	2	12065898
Pubmed	Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability.	AFF3 AFF4	2.70e-05	3	105	2	21330300
Pubmed	TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).	TET1 KMT2A	2.70e-05	3	105	2	12646957
Pubmed	Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4.	CCNT1 AFF4	2.70e-05	3	105	2	24727379
Pubmed	PAK1 regulates ATXN1 levels providing an opportunity to modify its toxicity in spinocerebellar ataxia type 1.	ATXN1 PAK1	2.70e-05	3	105	2	29860311
Pubmed	AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).	KMT2A AFF4	2.70e-05	3	105	2	10588740
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZNF845 MYCBP2 BCORL1 MAML1 CGGBP1 THOC2 PRDM2 CCNT1 TLE3 KMT2A TP53BP1 ZNF292 RAVER1	2.88e-05	1103	105	13	34189442
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYCBP2 SRPK1 NCBP1 THOC2 NKRF TASOR2 ZNF638 KMT2A RBM34 TP53BP1	2.96e-05	653	105	10	22586326
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	USP36 ZNF845 BCORL1 THOC2 NKRF TASOR2 CCNT1 ZNF638 KMT2A ZNF808 AFF4 TP53BP1	3.19e-05	954	105	12	36373674
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD ANK2 CLIP2 MYCBP2 SIPA1L3 NCBP1 NBEA SHTN1 CCDC13 MICAL2 PAK1 CADPS2 AFF4 ZNF292	3.28e-05	1285	105	14	35914814
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	PSD3 MARCKSL1 ADCY9 GPR158 BSG CADPS2 DCUN1D3 MARCKS	3.29e-05	405	105	8	38187761
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	MYCBP2 MAML1 MARCKSL1 TNRC6C BSG MARCKS RAVER1	4.24e-05	307	105	7	37499664
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TBC1D15 MYCBP2 SHTN1 THOC2 NKRF MTRF1 TET1 KMT2A TP53BP1	4.47e-05	549	105	9	38280479
Pubmed	The protein interaction landscape of the human CMGC kinase group.	ASXL1 SIPA1L3 AFF3 SRPK1 MARCKSL1 CCNT1 TLE3 NAV1 AFF4 RBM34	4.99e-05	695	105	10	23602568
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	CLIP2 PTDSS1 SRPK1 ABCF2 NCBP1 THOC2 NKRF CCNT1 ZNF638 KMT2A RBM34	5.22e-05	847	105	11	35850772
Pubmed	Isolation, characterization, and mapping of the mouse Fgd3 gene, a new Faciogenital Dysplasia (FGD1; Aarskog Syndrome) gene homologue.	ATXN1 FGD3	5.40e-05	4	105	2	10721717
Pubmed	Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.	TET1 KMT2A	5.40e-05	4	105	2	26791235
Pubmed	Mouse neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration.	CLIP2 NAV1	5.40e-05	4	105	2	15797708
Pubmed	Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.	AFF3 AFF4	5.40e-05	4	105	2	11923441
Pubmed	Differential chromatin looping regulates CD4 expression in immature thymocytes.	CCNT1 AFF4	5.40e-05	4	105	2	18039856
Pubmed	HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold.	CCNT1 AFF4	5.40e-05	4	105	2	23251033
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	CYLD NYAP2 CLIP2 SIPA1L3 SRCIN1 TNRC6C	5.44e-05	218	105	6	33378226
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ABI1 SIPA1L3 TMEM199 SRCIN1 SHTN1 ADCY9 PPL BSG MARCKS	5.58e-05	565	105	9	25468996
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ANK2 CLIP2 SIPA1L3 SRPK1 NCBP1 MARCKSL1 CGGBP1 THOC2 NKRF KMT2A DCUN1D3 MARCKS AFF4 RBM34	6.60e-05	1371	105	14	36244648
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	USP36 SRPK1 NCBP1 NKRF GLE1 ZNF638 RBM34	6.93e-05	332	105	7	25693804
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF845 TBC1D15 PTDSS1 ZNF813 ABCF2 NCBP1 THOC2 CCNT1 BSG MICAL2 GLE1 ZNF808 TP53BP1	6.97e-05	1203	105	13	29180619
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NKRF CCNT1 TLE3 ZNF638 KMT2A AFF4 TP53BP1	8.19e-05	341	105	7	32971831
Pubmed	Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells.	ABI1 PAK1	8.97e-05	5	105	2	11956071
Pubmed	Reactive oxygen species-dependent down-regulation of tumor suppressor genes PTEN, USP28, DRAM, TIGAR, and CYLD under oxidative stress.	CYLD TIGAR	8.97e-05	5	105	2	23832602
Pubmed	Interaction network of human early embryonic transcription factors.	BCORL1 MAML1 PRDM2 ATXN1 TLE3 TET1 KMT2A	9.80e-05	351	105	7	38297188
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	TBC1D15 SRPK1 MARCKSL1 SRCIN1 PAK1 MARCKS	1.06e-04	246	105	6	15345747
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MYCBP2 PTDSS1 NCBP1 CGGBP1 THOC2 NKRF ZNF8 ZNF638 KDM1B MARCKS AFF4 ZNF292	1.06e-04	1082	105	12	38697112
Pubmed	A human MAP kinase interactome.	CCDC14 CLIP2 KIF26B ZC3H7A ZNF600 ATXN1 PAK1 NAV1	1.17e-04	486	105	8	20936779
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	PARP2 SRPK1 NCBP1 ZNF638 KMT2A TP53BP1	1.18e-04	251	105	6	31076518
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	USP36 ANK2 SHTN1 THOC2 NKRF CCNT1 ZNF638 KMT2A MARCKS AFF4 TP53BP1	1.24e-04	934	105	11	33916271
Pubmed	Characteristics of the F52 protein, a MARCKS homologue.	MARCKSL1 MARCKS	1.34e-04	6	105	2	1618855
Pubmed	Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.	CCNT1 KMT2A	1.34e-04	6	105	2	21896721
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NBEA LPIN1 GPR158 ZNF292	1.44e-04	87	105	4	12465718
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TBC1D15 THOC2 ZNF8 TLE3 PAK1 ZNF638 TP53BP1 RAVER1	1.48e-04	503	105	8	16964243
Pubmed	SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation.	CCNT1 KMT2A	1.88e-04	7	105	2	19818711
Pubmed	Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.	CCNT1 KDM1B	1.88e-04	7	105	2	20670891
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	ABI1 ANK2 CLIP2	1.93e-04	37	105	3	27565344
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP36 SMG1 NYAP2 SASH1 MAML1 SRCIN1 ADCY9 TET1	2.08e-04	529	105	8	14621295
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF845 ZNF813 ZNF8 ZNF611 ZNF701	2.29e-04	181	105	5	37372979
Pubmed	Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.	ABCF2 THOC2 NKRF CCNT1 ZNF701	2.35e-04	182	105	5	32239614
Pubmed	Developmental expression of MARCKS and protein kinase C in mice in relation to the exencephaly resulting from MARCKS deficiency.	MARCKSL1 MARCKS	2.50e-04	8	105	2	8922669
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	ASXL1 KMT2A	2.50e-04	8	105	2	22722839
Interaction	PFN1 interactions	USP36 CYLD ABI1 ANK2 SRPK1 NBEA CEP192 SHTN1 CCNT1 NAV1 MARCKS AFF4 TP53BP1	1.76e-06	509	102	13	int:PFN1
Interaction	CEP135 interactions	CCDC14 CYLD SIPA1L3 SRPK1 CEP192 TNRC6C IQCC CEP72 NAV1	9.98e-06	272	102	9	int:CEP135
Interaction	KRT8 interactions	CCDC14 CYLD SMG1 SIPA1L3 CEP192 TNRC6C PPL MTRF1 CEP72 BSG NAV1	1.45e-05	441	102	11	int:KRT8
Interaction	KDM1A interactions	CCDC14 CCDC74B TBC1D15 MYCBP2 BCORL1 SHTN1 THOC2 PRDM2 ZNF8 ATXN1 TLE3 TET1 CCDC74A NAV1 KDM1B TP53BP1	1.96e-05	941	102	16	int:KDM1A
Interaction	YWHAZ interactions	CYLD ASXL1 ABI1 SASH1 CLIP2 MYCBP2 KIF26B SIPA1L3 PSD3 CEP192 N4BP3 SHTN1 ATXN1 PAK1 ZNF638 NAV1 KMT2A MARCKS TP53BP1	3.04e-05	1319	102	19	int:YWHAZ
Interaction	ADARB1 interactions	USP36 ZNF845 ANK2 SRPK1 THOC2 NKRF CCNT1 GLE1 ZNF638 RBM34 TP53BP1	3.74e-05	489	102	11	int:ADARB1
Interaction	H3C3 interactions	ZNF845 BCORL1 ZNF813 NCBP1 PRDM2 ZNF8 KMT2A KDM1B AFF4 RBM34 ZNF292	4.18e-05	495	102	11	int:H3C3
Interaction	BCLAF1 interactions	CYLD ASXL1 ABI1 MYCBP2 SRPK1 THOC2 JARID2 ATXN1 GLE1	4.26e-05	327	102	9	int:BCLAF1
Interaction	H3C1 interactions	USP36 ANK2 PARP2 SRPK1 PRDM2 ATXN1 TLE3 PAK1 ZNF638 KMT2A KDM1B AFF4 RBM34 TP53BP1 ZNF292	4.66e-05	901	102	15	int:H3C1
Interaction	YWHAG interactions	CYLD ABI1 SASH1 MYCBP2 KIF26B SIPA1L3 PSD3 SRPK1 CEP192 N4BP3 SHTN1 LPIN1 ATXN1 TET1 PAK1 ZNF638 NAV1 KMT2A	5.00e-05	1248	102	18	int:YWHAG
Interaction	TNRC6C interactions	CYLD CEP192 TNRC6C ZC3H7A IQCC RAVER1	7.26e-05	138	102	6	int:TNRC6C
Interaction	SYNE3 interactions	CCDC14 CYLD SIPA1L3 CEP192 TNRC6C ADCY9 IQCC CEP72 NAV1 RAVER1	8.51e-05	444	102	10	int:SYNE3
Interaction	CNOT3 interactions	NBEA TNRC6C THOC2 ZC3H7A ATXN1 MARCKS RAVER1	8.82e-05	207	102	7	int:CNOT3
Interaction	ZNF330 interactions	USP36 SEMG1 BCORL1 SRPK1 NKRF ZNF8 KMT2A AFF4 RBM34 ZNF292	8.83e-05	446	102	10	int:ZNF330
Interaction	AP2B1 interactions	USP36 CYLD SIPA1L3 CEP192 TNRC6C ATXN1 BSG NAV1 AFF4	1.17e-04	373	102	9	int:AP2B1
Interaction	CENPA interactions	USP36 PARP2 BCORL1 THOC2 DSN1 PRDM2 KMT2A RBM34 ZNF292	1.26e-04	377	102	9	int:CENPA
Interaction	BTG3 interactions	MYCBP2 CCDC13 ATXN1 PAK1 AFF4	1.41e-04	98	102	5	int:BTG3
Interaction	YWHAQ interactions	CYLD ABI1 SASH1 MYCBP2 KIF26B SIPA1L3 PSD3 CEP192 N4BP3 SHTN1 ATXN1 TET1 ZNF638 NAV1 KMT2A ULK4	1.51e-04	1118	102	16	int:YWHAQ
Interaction	ODF2 interactions	CCDC14 CYLD SIPA1L3 CEP192 TNRC6C CEP72	1.53e-04	158	102	6	int:ODF2
Interaction	FXR1 interactions	SMG1 ABI1 MYCBP2 N4BP3 THOC2 TASOR2 ZC3H7A ATXN1 CEP72 GLE1 PAK1 TP53BP1	1.64e-04	679	102	12	int:FXR1
Interaction	YWHAE interactions	CYLD ABI1 SASH1 MYCBP2 KIF26B SIPA1L3 PSD3 NCBP1 SRCIN1 N4BP3 SHTN1 LPIN1 ATXN1 TET1 ZNF638 NAV1 KMT2A	1.80e-04	1256	102	17	int:YWHAE
Interaction	RNF41 interactions	CYLD SIPA1L3 CEP192 N4BP3 SHTN1 NAV1	1.87e-04	164	102	6	int:RNF41
Interaction	ETV6 interactions	CYLD CEP192 TNRC6C TLE3 TP53BP1	1.95e-04	105	102	5	int:ETV6
Interaction	SFN interactions	CYLD SASH1 MYCBP2 KIF26B SIPA1L3 CEP192 N4BP3 SHTN1 ATXN1 ZNF638 NAV1 KMT2A	1.96e-04	692	102	12	int:SFN
Interaction	DUSP16 interactions	CCDC14 TRO CEP192 DSN1 TASOR2 GLE1 NAV1	2.04e-04	237	102	7	int:DUSP16
Interaction	KDM1B interactions	CYLD CEP192 CCNT1 KDM1B	2.13e-04	58	102	4	int:KDM1B
Interaction	RPL13 interactions	USP36 CYLD ZNF845 TRO ZNF813 SRPK1 NKRF GLE1 ZNF638 KMT2A RBM34 RAVER1	2.18e-04	700	102	12	int:RPL13
Interaction	SMG7 interactions	SMG1 MAML1 TNRC6C NKRF ZC3H7A TLE3 TET1 RAVER1	2.18e-04	319	102	8	int:SMG7
Interaction	EGR2 interactions	BCORL1 MAML1 ATXN1 TLE3 TET1 KMT2A	2.35e-04	171	102	6	int:EGR2
Cytoband	19q13.41	ZNF321P ZNF600 ZNF611 ZNF808 ZNF701	1.05e-06	78	105	5	19q13.41
Cytoband	7q31.3	PTPRZ1 CADPS2	5.34e-04	15	105	2	7q31.3
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF845 ZNF321P SIPA1L3 ZNF813 ZNF8 ZNF600 ZNF611 ZNF808 ZNF701	1.69e-03	1192	105	9	chr19q13
Cytoband	16p12.3	SMG1 DCUN1D3	2.77e-03	34	105	2	16p12.3
Cytoband	3p22.1	CCDC13 ULK4	3.82e-03	40	105	2	3p22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr7q31	ASB15 PTPRZ1 CADPS2	4.15e-03	140	105	3	chr7q31
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF4	8.32e-05	4	68	2	1145
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF4	4.93e-04	9	68	2	1280
GeneFamily	Zinc fingers CXXC-type	TET1 KMT2A	8.98e-04	12	68	2	136
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF845 ZNF391 ZNF813 ZNF8 ZNF600 ZNF611 ZNF808 ZNF701 ZNF292	1.41e-03	718	68	9	28
GeneFamily	Ankyrin repeat domain containing	ANKRD31 ANK2 BCORL1 ASB15 ANKRD33B	2.16e-03	242	68	5	403
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CYLD SYCP2L FRMPD4 ANK2 MYCBP2 BIVM AFF3 NBEA SRCIN1 TNRC6C SHTN1 PRDM2 LPIN1 GPR158 NAV1 CSMD1	6.44e-06	1106	103	16	M39071
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	SMG1 MYCBP2 MARCKSL1 IQCC CD68 KMT2A AFF4	1.00e-05	189	103	7	M3112
Coexpression	GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN	SIPA1L3 BCORL1 NBEA KMT2A CADPS2 ANKRD33B FGD3	1.40e-05	199	103	7	M7472
Coexpression	GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	CCDC14 WDR64 SASH1 PSD3 MARCKSL1 TET1 TP53BP1	1.45e-05	200	103	7	M304
Coexpression	GABRIELY_MIR21_TARGETS	CCDC14 SASH1 MYCBP2 NBEA THOC2 LPIN1 TET1 ZNF292	1.91e-05	289	103	8	M2196
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ASXL1 ABI1 SASH1 MYCBP2 PSD3 THOC2 ADCY9 JARID2 ATXN1 MICAL2 ZNF638 TP53BP1 ZNF292	3.12e-05	856	103	13	M4500
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	CYLD SMG1 ZNF845 TMEM199 CEP192 SHTN1 DSN1 NKRF TASOR2 ZNF600 CEP72 TET1 PAK1 HFM1 KDM1B PHYHIPL CCDC191	3.54e-07	820	102	17	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500	ZNF845 TMEM199 CEP192 SHTN1 TET1 CCDC191	9.28e-06	101	102	6	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000	CCDC14 SYCP2L ZNF845 BCORL1 CEP192 SHTN1 NKRF JARID2 CCNT1 PTPRZ1 TET1 PAK1 ZNF638 NAV1 PHYHIPL RAVER1	2.03e-05	994	102	16	Facebase_RNAseq_e8.5_Floor Plate_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500	ZNF845 TMEM199 CEP192 SHTN1 NKRF ZNF600 TET1 PAK1 HFM1 CCDC191	2.60e-05	406	102	10	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	ZNF845 TMEM199 NCBP1 CEP192 TNRC6C SHTN1 DSN1 NKRF TASOR2 ZNF600 TET1 PAK1 HFM1 CCDC191	3.26e-05	810	102	14	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	BCORL1 CEP192 NKRF PTPRZ1 TET1 PAK1 ZNF638 PHYHIPL	3.59e-05	259	102	8	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	CCDC14 ZNF845 TMEM199 ABCF2 CEP192 SHTN1 NKRF TASOR2 JARID2 ZNF600 TET1 PAK1 HFM1 CCDC191	3.83e-05	822	102	14	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	CCDC14 USP36 TIGAR ZNF845 ZNF813 SRPK1 NCBP1 CEP192 NKRF JARID2 IQCC BSG PTPRZ1 TET1 PAK1 NAV1 CADPS2 PHYHIPL	8.59e-05	1371	102	18	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500	CYLD ZNF845 NKRF TASOR2 ZNF600 PAK1 HFM1 PHYHIPL CCDC191	1.00e-04	385	102	9	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	CCDC14 ZNF845 TMEM199 CEP192 SHTN1 NKRF JARID2 ZNF600 TET1 PAK1 HFM1 PHYHIPL CCDC191	1.11e-04	795	102	13	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500	ZNF845 TMEM199 CEP192 SHTN1 ZNF600 TET1 PAK1 HFM1 CCDC191	1.24e-04	396	102	9	gudmap_dev gonad_e13.5_M_GermCell_Oct_500
CoexpressionAtlas	dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200	NYAP2 ANK2 PTPRZ1 PHYHIPL	1.42e-04	55	102	4	gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k1_200
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000	TMEM199 NCBP1 CEP192 TNRC6C DSN1 NKRF PAK1 CCDC191	2.05e-04	333	102	8	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	SYCP2L ZNF845 ANK2 KIF26B SHTN1 NKRF ZC3H7A ATXN1 PTPRZ1 PAK1 CD68 KDM1B POLQ PHYHIPL	2.53e-04	983	102	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ANK2 SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	5.89e-09	169	103	8	3f8aa6d2f9aa060ae1a0ea3eb47e794099fc2c2c
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ANK2 SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	5.89e-09	169	103	8	26de495c7562e0740689d0f78e803698e3e793db
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ANK2 SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	6.17e-09	170	103	8	670027daec5a10dfa12246f1497b58db21d32a22
ToppCell	mLN-Dendritic_cell-Lymphoid_DC\|Dendritic_cell / Region, Cell class and subclass	PSD3 MARCKSL1 ZC3H7A ATXN1 NAV1 SNX11 ANKRD33B MARCKS	2.20e-08	200	103	8	3813fa1ee1462ba83fd8b6253070f46f0b063084
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	1.48e-07	171	103	7	35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	1.94e-07	178	103	7	6c1b5087581ca8cea976d89ea6f34088c8fc3668
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 NBEA GPR158 MICAL2 PAK1 CSMD1	3.99e-07	198	103	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	droplet-Spleen-nan-3m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	2.45e-06	166	103	6	c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3
ToppCell	droplet-Spleen-nan-3m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	2.45e-06	166	103	6	94c30d6ca179d0cb02a5ed0093c5a2871e17ae50
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|356C / Donor, Lineage, Cell class and subclass (all cells)	PSD3 MARCKSL1 NAV1 SNX11 ANKRD33B MARCKS	2.54e-06	167	103	6	43a9375fdbafd7450c553e4620e21537e08639dd
ToppCell	ILEUM-non-inflamed-(3)_mature_DC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PSD3 MARCKSL1 BSG NAV1 ANKRD33B MARCKS	2.81e-06	170	103	6	60151394460e6f27a42fab434e8b7b2adc78b128
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	2.91e-06	171	103	6	4a2e6ea9674bf23e8012ef0bb2bf19ce1f55fcd5
ToppCell	droplet-Spleen-nan-3m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	2.91e-06	171	103	6	5b74df72e36ad04dfb25c72f1ca8efe043f6cda6
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	3.01e-06	172	103	6	4fe5b91e4871bc6c5be57eb5b8bb04815b2fb80d
ToppCell	droplet-Spleen-nan-18m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	3.01e-06	172	103	6	850e4c9e9003807c19695be4b13121b0808a9389
ToppCell	droplet-Spleen-nan-18m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SHTN1 PAK1 NAV1 CD68 MARCKS	3.01e-06	172	103	6	018d8160cfcb7882475620dc678f48a69a0f643e
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYLD MYCBP2 AFF3 PRDM2 ANKRD33B MARCKS	4.58e-06	185	103	6	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSD3 MARCKSL1 JARID2 NAV1 ANKRD33B MARCKS	4.58e-06	185	103	6	48de4d9fad55077732bf64eca4919103ecbc1512
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 JARID2 ZNF638 MARCKS AFF4 ZNF292	5.66e-06	192	103	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_mature_DC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PSD3 MARCKSL1 NAV1 SNX11 ANKRD33B MARCKS	5.83e-06	193	103	6	d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	PSD3 MARCKSL1 NAV1 SNX11 ANKRD33B MARCKS	5.83e-06	193	103	6	024d30eb143d8278c0851c3a6c9426226fa3b480
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 JARID2 ZNF638 MARCKS AFF4 ZNF292	5.83e-06	193	103	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 NBEA GPR158 MICAL2 CSMD1	6.37e-06	196	103	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	CYLD SMG1 MARCKSL1 KMT2A AFF4 ZNF292	6.37e-06	196	103	6	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 TNRC6C LPIN1 CCNT1 ZNF600 ZNF292	6.56e-06	197	103	6	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 NBEA GPR158 MICAL2 CSMD1	6.75e-06	198	103	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 NBEA MICAL2 PAK1 CSMD1	6.75e-06	198	103	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SASH1 SHTN1 PAK1 CD68 KDM1B MARCKS	6.95e-06	199	103	6	18b6087863fda22e3e2a2167e7daeb347df1d95b
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	FRMPD4 MYCBP2 AFF3 NBEA MICAL2 CSMD1	7.15e-06	200	103	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 MYCBP2 PRDM2 KMT2A AFF4 ZNF292	7.15e-06	200	103	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	SYCP2L TASOR2 JARID2 TLE3 HFM1	2.51e-05	149	103	5	768877bade04ca0321593b8470b5011ad8270431
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_2\|343B / Donor, Lineage, Cell class and subclass (all cells)	CEP72 PAK1 CD68 ANKRD33B MCEMP1	3.03e-05	155	103	5	84221a285277292f7225eb69508c887541abeed1
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pre-B\|bone_marrow / Manually curated celltypes from each tissue	AFF3 CLEC20A NAV1 CCDC191 MARCKS	3.75e-05	162	103	5	e088e66aabc307dde5d2b9aa295c34ef68155b1a
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MARCKSL1 N4BP3 PPL CCDC13 CCDC191	3.97e-05	164	103	5	1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518
ToppCell	droplet-Spleen-nan-21m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHTN1 PAK1 NAV1 CD68 MCEMP1	4.09e-05	165	103	5	fbd84f211ad645c91b9f45a0815391606f3206ac
ToppCell	droplet-Spleen-nan-21m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHTN1 PAK1 NAV1 CD68 MCEMP1	4.09e-05	165	103	5	6fbdfacb49e627712ac999d40ae22dcb390edd3e
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SASH1 SRCIN1 SHTN1 CD68 MARCKS	4.21e-05	166	103	5	91eeb48680dd07ae4115afacdc0a8f6fa18885e5
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	N4BP3 NKRF HFM1 ANKRD33B MARCKS	4.58e-05	169	103	5	41ad349806b279fbe1374b7e3cc7f146a11adb44
ToppCell	356C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SYCP2L TIGAR PTDSS1 ZNF808 CCDC191	4.58e-05	169	103	5	0425d2580ed325178f522c0093ff4623de6ce7a8
ToppCell	356C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SYCP2L TIGAR PTDSS1 ZNF808 CCDC191	4.58e-05	169	103	5	fec669968a77060bd77ee8695034e35a642c984f
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	N4BP3 NKRF HFM1 ANKRD33B MARCKS	4.58e-05	169	103	5	42782c61592742190ab0cba8a94f8bdf9c278f90
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	PSD3 MARCKSL1 SNX11 ANKRD33B MARCKS	4.71e-05	170	103	5	513d9036aa41d4d902da8baa66a66206abb6f3b0
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SIPA1L3 AFF3 N4BP3 ANKRD33B MARCKS	4.85e-05	171	103	5	b6ee3a6bc436df5e9129b8e0bed9fa3078a4ff23
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC\|lymph-node_spleen / Manually curated celltypes from each tissue	SEMG1 PSD3 MARCKSL1 NAV1 ANKRD33B	4.98e-05	172	103	5	1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCORL1 NBEA ADCY9 LPIN1 ANKRD33B	5.12e-05	173	103	5	62abaaaf48cabd1423f17fb27c33b75ea88867f4
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCORL1 NBEA ADCY9 LPIN1 ANKRD33B	5.12e-05	173	103	5	09cd878c33534bd476d6a4880f5582076189da8c
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIGAR SASH1 N4BP3 ZNF8 HFM1	5.56e-05	176	103	5	7292e014b8f697f0c2e9f47c48333de95cb44a69
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIGAR SASH1 N4BP3 ZNF8 HFM1	5.56e-05	176	103	5	88ca2f83d8301633232735f39b0683efe49d0b86
ToppCell	facs-Marrow-KLS-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHTN1 PAK1 NAV1 CD68 MARCKS	5.86e-05	178	103	5	6bad4439a1692332f70135ff446a1048fa4c399d
ToppCell	facs-Marrow-KLS-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHTN1 PAK1 NAV1 CD68 MARCKS	5.86e-05	178	103	5	3f6feb4ed7779cf5684f52939350b41d7718c3c6
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 KIF26B PSD3 PPL NAV1	6.18e-05	180	103	5	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages\|bone_marrow / Manually curated celltypes from each tissue	PSD3 SHTN1 NAV1 CD68 MARCKS	6.18e-05	180	103	5	daf69a548ed7c6f285a6adcff00f99aa22f9d6a5
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYLD AFF3 PRDM2 LPIN1 ANKRD33B	6.34e-05	181	103	5	d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYCBP2 SIPA1L3 AFF3 PRDM2 ANKRD33B	6.34e-05	181	103	5	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYCBP2 SIPA1L3 AFF3 PRDM2 ANKRD33B	6.86e-05	184	103	5	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KIF26B AFF3 MARCKSL1 PAK1 MARCKS	6.86e-05	184	103	5	0a26bcc6610f756939e32a4d6dfeebcbf3a1db86
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYCBP2 SIPA1L3 AFF3 PRDM2 ANKRD33B	6.86e-05	184	103	5	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KIF26B AFF3 MARCKSL1 PAK1 MARCKS	7.04e-05	185	103	5	fec16a5e527fdef32d25957451b6e8ee9796cafd
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	CCDC14 MYCBP2 CCNT1 POLQ ZNF292	7.22e-05	186	103	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	normal_Lung-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	MARCKSL1 GPR158 NAV1 ANKRD33B MARCKS	7.22e-05	186	103	5	00ad1239b952119b3fd2e6af8f034cba3488f9c1
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	SIPA1L3 AFF3 PRDM2 ANKRD33B MARCKS	7.40e-05	187	103	5	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	390C-Myeloid-Dendritic-cDC_activated\|390C / Donor, Lineage, Cell class and subclass (all cells)	PSD3 MARCKSL1 NAV1 ANKRD33B MARCKS	7.40e-05	187	103	5	60c2576f31a60f819deb9ec500d1f714b469df4e
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SMG1 PRDM2 TASOR2 KMT2A TP53BP1	7.59e-05	188	103	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COPD-Myeloid-DC_Mature\|COPD / Disease state, Lineage and Cell class	SIPA1L3 MARCKSL1 NAV1 ANKRD33B MARCKS	7.59e-05	188	103	5	de93ccb53edb8599da9e312db0e3af604c21f673
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 SIPA1L3 PPL PHYHIPL ANKRD33B	7.59e-05	188	103	5	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	NYAP2 FRMPD4 MYCBP2 GPR158 KMT2A	7.98e-05	190	103	5	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYCBP2 AFF3 PRDM2 CLEC20A CCDC191	7.98e-05	190	103	5	a7498fe55b7810c482291db782dc5282675d246a
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	PSD3 MARCKSL1 NAV1 ANKRD33B MARCKS	7.98e-05	190	103	5	15978ddd37b521343f88b62dad1643077fc22b2b
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 N4BP3 PRDM2 ANKRD33B MARCKS	7.98e-05	190	103	5	95b9334573eefb132daaa9371377ad60232006ae
ToppCell	10x5'-GI_small-bowel-Myeloid_Dendritic-migDC\|GI_small-bowel / Manually curated celltypes from each tissue	PSD3 MARCKSL1 PAK1 NAV1 MARCKS	7.98e-05	190	103	5	e9b2c201d07f0cb87fa60005251c9e1663e246ed
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	SIPA1L3 AFF3 PRDM2 ANKRD33B MARCKS	7.98e-05	190	103	5	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	Control-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	SIPA1L3 AFF3 JARID2 PAK1 CSMD1	8.18e-05	191	103	5	11dfd8f38beb294f42710cfbd355cb089e1023c0
ToppCell	Fetal_29-31_weeks-Immune-B_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SIPA1L3 AFF3 PRDM2 CCDC191 ANKRD33B	8.18e-05	191	103	5	84452125d1b5b76974e3f9126f611eff16d45c25
ToppCell	COPD-Myeloid-cDC2\|COPD / Disease state, Lineage and Cell class	SIPA1L3 AFF3 JARID2 PAK1 CSMD1	8.18e-05	191	103	5	2af6e4a6bd1f2193ece2131c3b7d976dd23a6966
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 N4BP3 PRDM2 ANKRD33B MARCKS	8.18e-05	191	103	5	22134a2c1a92208bc1629a620ce73a56502613c2
ToppCell	COPD-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	SIPA1L3 AFF3 JARID2 PAK1 CSMD1	8.18e-05	191	103	5	4e4887175200a57e1b041f2f131e3df774df3509
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SIPA1L3 AFF3 PRDM2 CCDC191 MARCKS	8.18e-05	191	103	5	5a9a592875fbd0b1429b48db29a760fdc9c2c856
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	SIPA1L3 AFF3 JARID2 PAK1 CSMD1	8.38e-05	192	103	5	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	COPD-Myeloid-DC_Mature\|Myeloid / Disease state, Lineage and Cell class	SIPA1L3 MARCKSL1 NAV1 ANKRD33B MARCKS	8.38e-05	192	103	5	baebd462f464e7d0e462d07a74bb5d685a9fc3b6
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 N4BP3 PRDM2 ANKRD33B MARCKS	8.38e-05	192	103	5	debd471f61cf3606b8e9c246add0be5df601af7f
ToppCell	COVID-19_Mild-Lymphoid_B-B_memory\|COVID-19_Mild / Disease group, lineage and cell class	AFF3 N4BP3 PRDM2 ANKRD33B MARCKS	8.38e-05	192	103	5	d27db7669de95bddbea8ccb83e6f10ae7240b1ab
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 N4BP3 PRDM2 ANKRD33B MARCKS	8.38e-05	192	103	5	314f74dd3c6d94839eed05b9a1a398217ef78029
ToppCell	367C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	PSD3 MARCKSL1 ZC3H7A ANKRD33B MARCKS	8.38e-05	192	103	5	e44e37e5aeba8628556020d05e1606b28e2faa4f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ASXL1 AFF3 N4BP3 PRDM2 ANKRD33B	8.59e-05	193	103	5	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 THOC2 PRDM2 CCDC191 MARCKS	8.59e-05	193	103	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SIPA1L3 AFF3 PRDM2 CLEC20A CCDC191	8.59e-05	193	103	5	d5d188a314da1b4c8390276d88173c09dd7ce4bf
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	CLIP2 MYCBP2 PRDM2 ANKRD33B MARCKS	8.59e-05	193	103	5	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	ILEUM-inflamed-(3)_mature_DC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MARCKSL1 BSG NAV1 ANKRD33B MARCKS	8.80e-05	194	103	5	369bbf4e8e2d674e5a51a614b52b97d05d3ab9c7
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MARCKSL1 JARID2 TLE3 MARCKS MCEMP1	8.80e-05	194	103	5	3ef9e88e66f2f2ae95dcc834ea605c40c60783fc
ToppCell	3'_v3-Lung-Myeloid_Dendritic\|Lung / Manually curated celltypes from each tissue	AFF3 MARCKSL1 PAK1 NAV1 ANKRD33B	9.01e-05	195	103	5	b748cb15846345363e8c2ee5936bb42bba3ba9a7
ToppCell	BAL-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MARCKSL1 PAK1 NAV1 ANKRD33B MARCKS	9.01e-05	195	103	5	6ba23e19801305e071b0e4aaf1ee6f53f3b027d3
ToppCell	BAL-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MARCKSL1 PAK1 NAV1 ANKRD33B MARCKS	9.01e-05	195	103	5	66e5fd9f3208a06d617c5e994822bf57dceae7e2
ToppCell	BAL-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MARCKSL1 PAK1 NAV1 ANKRD33B MARCKS	9.01e-05	195	103	5	7209babdff96c93cd52cfe5d5cfd7e3c0274d8dd
ToppCell	BAL-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MARCKSL1 PAK1 NAV1 ANKRD33B MARCKS	9.01e-05	195	103	5	9e5cf33b5dd455efa464a63d7116786c0786aefd
ToppCell	Mild_COVID-19-Myeloid-cDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MARCKSL1 PAK1 NAV1 ANKRD33B MARCKS	9.01e-05	195	103	5	24149bb6933135b1a0a5c7f505914942b3782c3a
ToppCell	390C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PSD3 MARCKSL1 NAV1 ANKRD33B MARCKS	9.01e-05	195	103	5	ecf7d9856a5b507ec17c325c9a772dc5a184bc8e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 MICAL2 PAK1 CSMD1 CADPS2	9.01e-05	195	103	5	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	SIPA1L3 AFF3 ADCY9 ATXN1 CADPS2	9.23e-05	196	103	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Lung_Parenchyma-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 MARCKSL1 N4BP3 PRDM2 ANKRD33B	9.23e-05	196	103	5	279f113916dcb398111d787ae06bcf20ff8febd2
ToppCell	Parenchyma_Control_(B.)-Immune-TX-B_cells\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	AFF3 MARCKSL1 N4BP3 PRDM2 ANKRD33B	9.23e-05	196	103	5	a2759691606b03de9d67e8d38487915cd4e7d448
Disease	insulin resistance	USP36 NYAP2 ANK2 CSMD1	4.53e-05	59	98	4	EFO_0002614
Disease	blood manganese measurement	ADCY9 TLE3 CSMD1	9.81e-05	27	98	3	EFO_0007581
Disease	free cholesterol to total lipids in small VLDL percentage	ANKRD31 NYAP2 PSD3 TP53BP1	1.16e-04	75	98	4	EFO_0022287
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ANKRD31 NYAP2 PSD3 TP53BP1	1.97e-04	86	98	4	EFO_0008595, EFO_0020945
Disease	Neurodevelopmental Disorders	ANK2 PAK1 KMT2A ZNF292	2.66e-04	93	98	4	C1535926
Disease	myelofibrosis (is_implicated_in)	ASXL1 KMT2A	3.02e-04	8	98	2	DOID:4971 (is_implicated_in)
Disease	free cholesterol to total lipids in very small VLDL percentage	NYAP2 PSD3 TP53BP1	3.98e-04	43	98	3	EFO_0022290
Disease	ejection fraction measurement	ATXN1 GPR158 CADPS2	3.98e-04	43	98	3	EFO_0005527
Disease	glucagon-like peptide-1 measurement	ULK4 CSMD1	4.83e-04	10	98	2	EFO_0008465
Disease	Amyotrophic Lateral Sclerosis, Sporadic	BSG TLE3 CD68	5.51e-04	48	98	3	C1862941
Disease	Amyotrophic Lateral Sclerosis, Familial	BSG TLE3 CD68	5.51e-04	48	98	3	C4551993
Disease	mammographic density measurement	AFF3 NBEA ATXN1	6.22e-04	50	98	3	EFO_0005941
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	BSG TLE3 CD68	6.22e-04	50	98	3	C1862939
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	NYAP2 PSD3 TP53BP1	6.59e-04	51	98	3	EFO_0022302
Disease	Schizophrenia	ST6GALNAC1 PSD3 JARID2 PTPRZ1 TET1 NAV1 KMT2A ULK4 CSMD1 CADPS2	7.13e-04	883	98	10	C0036341
Disease	monoclonal gammopathy	ULK4 HFM1 CSMD1	7.38e-04	53	98	3	EFO_0000203
Disease	response to paliperidone, schizophrenia symptom severity measurement	NYAP2 AFF3 PSD3 ZNF611 CSMD1	7.85e-04	216	98	5	EFO_0007925, EFO_0007927
Disease	illegal drug consumption	WDR64 CSMD1	8.32e-04	13	98	2	EFO_0005431
Disease	triglycerides in LDL measurement	NYAP2 PSD3 TP53BP1	8.67e-04	56	98	3	EFO_0022320
Disease	free cholesterol to total lipids in medium VLDL percentage	ANKRD31 NYAP2 TP53BP1	9.13e-04	57	98	3	EFO_0022284
Disease	triglycerides to total lipids in small LDL percentage	NYAP2 PSD3 TP53BP1	1.01e-03	59	98	3	EFO_0022337
Disease	cholesteryl esters to total lipids in large HDL percentage	NYAP2 PSD3 TP53BP1	1.01e-03	59	98	3	EFO_0022248
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	NYAP2 PSD3 TP53BP1	1.06e-03	60	98	3	EFO_0021898
Disease	free cholesterol in very large VLDL measurement	ANKRD31 NYAP2 TP53BP1	1.11e-03	61	98	3	EFO_0022274
Disease	triglycerides in medium LDL measurement	NYAP2 PSD3 TP53BP1	1.17e-03	62	98	3	EFO_0022322
Disease	Vertigo	SYCP2L TIGAR ABI1 PRDM2	1.21e-03	139	98	4	HP_0002321
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 NYAP2 TP53BP1	1.22e-03	63	98	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 NYAP2 TP53BP1	1.22e-03	63	98	3	EFO_0022239
Disease	free cholesterol to total lipids in medium LDL percentage	NYAP2 PSD3 TP53BP1	1.22e-03	63	98	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	NYAP2 PSD3 TP53BP1	1.22e-03	63	98	3	EFO_0022292
Disease	triglycerides in small LDL measurement	NYAP2 PSD3 TP53BP1	1.34e-03	65	98	3	EFO_0022323
Disease	triacylglycerol 48:1 measurement	NYAP2 CSMD1	1.44e-03	17	98	2	EFO_0010404
Disease	emphysema imaging measurement	MROH9 MYCBP2 ZNF600 CSMD1	1.45e-03	146	98	4	EFO_0007626
Disease	triglycerides in very small VLDL measurement	NYAP2 PSD3 TP53BP1	1.52e-03	68	98	3	EFO_0022144
Disease	free cholesterol in large VLDL measurement	ANKRD31 NYAP2 TP53BP1	1.52e-03	68	98	3	EFO_0022265
Disease	reaction time measurement	CEP192 TNRC6C JARID2 CEP72 PTPRZ1 TET1 ZNF638 CSMD1	1.59e-03	658	98	8	EFO_0008393
Disease	triglycerides to total lipids in very small VLDL percentage	NYAP2 PSD3 TP53BP1	1.59e-03	69	98	3	EFO_0022341
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	ANKRD31 NYAP2 PSD3 TP53BP1	1.60e-03	150	98	4	EFO_0004611, EFO_0020947
Disease	inferior parietal cortex volume measurement	TBC1D15 SHTN1	1.80e-03	19	98	2	EFO_0010307
Disease	free cholesterol to total lipids in large LDL percentage	NYAP2 PSD3 TP53BP1	1.94e-03	74	98	3	EFO_0022280
Disease	Amphetamine-Related Disorders	PSD3 PRDM2 CSMD1	2.02e-03	75	98	3	C0236733
Disease	Amphetamine Abuse	PSD3 PRDM2 CSMD1	2.02e-03	75	98	3	C0236807
Disease	Amphetamine Addiction	PSD3 PRDM2 CSMD1	2.02e-03	75	98	3	C0236804
Disease	sex interaction measurement, cerebral amyloid angiopathy	SRCIN1 ADCY9	2.20e-03	21	98	2	EFO_0006790, EFO_0008343
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	NYAP2 PSD3 TP53BP1	2.26e-03	78	98	3	EFO_0022187
Disease	QRS duration, response to sulfonylurea	ZNF638 CSMD1	2.64e-03	23	98	2	EFO_0005055, EFO_0007922
Disease	sensory peripheral neuropathy, remission	KMT2A CSMD1	2.64e-03	23	98	2	EFO_0009785, MONDO_0002321
Disease	nicotine dependence symptom count	SYCP2L CLIP2 MYCBP2 NBEA CSMD1	2.65e-03	285	98	5	EFO_0009262
Disease	Rheumatoid Arthritis	ABCC3 AFF3 TLE3 MARCKS	2.74e-03	174	98	4	C0003873
Disease	pulmonary embolism	ZNF808 ZNF701	3.12e-03	25	98	2	EFO_0003827
Disease	heel bone mineral density, urate measurement	ANKRD31 AFF3 PSD3 MAML1	3.22e-03	182	98	4	EFO_0004531, EFO_0009270

Protein segments in the cluster

Peptide	Gene	Start	Entry
SQLVSSGHNNPKKGD	AFF3	336	P51826
GHGSAKLARQAQSKE	ABCF2	346	Q9UG63
PSKDGSHKNSVLSQG	CSMD1	326	Q96PZ7
KSPRGASDSGKEHNG	BCORL1	1161	Q5H9F3
KSGLTPIHSAADGQN	ASB15	306	Q8WXK1
LKAKHGNNQPARTGT	ABI1	156	Q8IZP0
NDSGNGEHKSERKSP	BIVM	11	Q86UB2
ASSKEGSPLHKQSSG	CLIP2	36	Q9UDT6
ATPNGTKGKDESQHT	GLE1	101	Q53GS7
SRHVKNGGSIPKSDQ	CGGBP1	131	Q9UFW8
GSHSALPGKKTALQA	CEP72	406	Q9P209
HSKLDKGPTGANGHN	CCNT1	636	O60563
SPSTLNDKSGLHLGK	ATXN1	406	P54253
QKKDGPSGNHLSRAS	CCDC74A	96	Q96AQ1
QKKDGPSGNHLSRAS	CCDC74B	96	Q96LY2
SSGRHTGPAKLTNGK	CCDC14	61	Q49A88
GSKNGDREPSNKSHS	DCUN1D3	16	Q8IWE4
GPLKANAENRKATGH	ASXL1	1376	Q8IXJ9
DKNSAGHKPSSNRES	AFF4	786	Q9UHB7
PARKGSTKDSGHLQI	ANKRD33B	441	A6NCL7
KQSHLSKAIGSSPLG	RAVER1	501	Q8IY67
GLNFTSKTAEGHPKS	RBM34	386	P42696
GTSNEPSHEGQKKQR	IQCC	416	Q4KMZ1
QTARHKASAAPGKNA	ABCC3	266	O15438
ANPKAEGLLQGKHST	PARP2	501	Q9UGN5
VHKSRKDHSSGNPGQ	PALM2	246	Q8IXS6
AFQSGQDPSKHKTGL	ANK2	1996	Q01484
AAQGTGNDCPHKKSA	CD68	16	P34810
STGLRKGNLHNVKDP	ANKRD31	706	Q8N7Z5
KPSGADALQSSGKHS	MAML1	166	Q92585
DGGQPHKRRKTSDAN	NCBP1	11	Q09161
KGKPHAQQPGRASAS	GPR158	41	Q5T848
ANKHGSKPSSLGVSN	KIF26B	261	Q2KJY2
KGPNGESSVIHDRKS	PPL	1701	O60437
KNGDPSGLAKHASDN	LPIN1	416	Q14693
QKADKDAGLAQHSGP	FGD3	141	Q5JSP0
PKLDNKERGHHGASS	NYAP2	556	Q9P242
PSANGLSQKHNDGKE	PTPRZ1	1506	P23471
DIGTNKPTNGKSHSL	MROH9	206	Q5TGP6
GTTASKKPGNRECNH	HFM1	1131	A2PYH4
NGHVKSNGDLSPKGE	MARCKSL1	31	P49006
AGSKDAGTLNHGSKP	PAK1	26	Q13153
HSKFDKDGQPLSGNR	ERVK-5	596	Q9HDB9
AATGNASPGKLEHSK	KDM1B	241	Q8NB78
TATQETGPENKGKHN	FRMPD4	531	Q14CM0
KNHDLSPGSRNGFKD	POLQ	1781	O75417
SLSAPGNKQHKTLGA	CCDC191	511	Q8NCU4
GLSLLHAGEPNSKNS	CCDC13	56	Q8IYE1
GSSPKKGGNCDLSHQ	DSN1	56	Q9H410
GSAPLKSSGQHQNDK	BSG	361	P35613
DEHKNSTKASGGPNP	ADCY9	656	O60503
TQKLNPKGGTLHADA	CADPS2	601	Q86UW7
SSPSKANGQENGHVK	MARCKS	26	P29966
KNQDHAKGGHSRPTS	MCEMP1	46	Q8IX19
KNSDLKNTSPEHGGR	CEP192	961	Q8TEP8
GNSSKQKIPADGVHR	KMT2A	1386	Q03164
VGDKGSSSHNKPKAT	CYLD	326	Q9NQC7
RNGSKEGNHHSTQPK	FAM104B	11	Q5XKR9
LRKTNSNKDGDQHSP	MICAL2	1576	O94851
KGGHSSPASSDKNSN	PRDM2	1496	Q13029
KSTPGRQAHGKADSA	JARID2	506	Q92833
KSEHSLFQAKGSPAG	NAV1	141	Q8NEY1
KDNSGSHGSPISGKL	PHYHIPL	211	Q96FC7
RQSSSHLAKGDQPKS	SNX11	166	Q9Y5W9
DSSSVLGHLGDGKKN	TNRC6C	601	Q9HCJ0
PLGKNHSSKVNSDSG	TIGAR	171	Q9NQ88
PSKGQKRHLSTCDGQ	NKRF	26	O15226
RDRGNKSSHGSSKPQ	NBEA	1491	Q8NFP9
NAGRNSASPKHSLNG	SMG1	1151	Q96Q15
KGGKAHRGTQNPSQD	SEMG1	131	P04279
AKEGSGFTKQSHQSP	PPP1R32	201	Q7Z5V6
GAKGDSHNGQPAKDS	SIPA1L3	256	O60292
KTKARAGAEQHSAGA	SIPA1L3	856	O60292
NKHPSRQDAAGKDSP	SIPA1L3	1241	O60292
QPKAHTTGDRGKEAN	ST6GALNAC1	91	Q9NSC7
SHPSGSGAKKEKATQ	SHTN1	381	A0MZ66
GSASKGKQQTSEPVH	MYCBP2	1391	O75592
QEHNGPLDNKGKSTA	SRPK1	461	Q96SB4
RAKGAGGQHVNKTDS	MTRF1	306	O75570
LAGSKQATLGAKPDH	TET1	331	Q8NFU7
SKEKTSAQKSGHPFG	CLEC20A	336	Q6ZU45
AGNKPIKDQLGSSFH	ZNF845	131	Q96IR2
RHAGNKPIKDQLGSS	ZNF321P	76	Q8N8H1
KHKGGDSSSGPQRLV	TMEM199	41	Q8N511
VKPSGRQIGKLSHSN	THOC2	561	Q8NI27
GHKVKGLTQDSNLPS	SPEM3	926	A0A1B0GUW6
AAQGQAGSPDKSKHG	SRCIN1	1111	Q9C0H9
RKSKHLNGDERSGSN	TRO	411	Q12816
PSSGSGHEKDQAKLL	SYCP2L	551	Q5T4T6
GPQNTRSSHLNKKGN	ZNF292	1611	O60281
DKDHPNTGNKKGSHS	ZNF292	2611	O60281
HAGNKPIKDQLGSSF	ZNF808	146	Q8N4W9
PLHKSNSEDSSVGKG	SASH1	131	O94885
SSDAEAQKLGKPSAH	TP53BP1	876	Q12888
HTNGDAPSHRNGKSK	TBC1D15	111	Q8TC07
AGNKPIKDQLGSSFH	ZNF813	131	Q6ZN06
TKDLGHNDKSSTPGL	TLE3	301	Q04726
KSVPGDGATKALNHS	ZC3H7A	186	Q8IWR0
QHPNSRKSSAGGAKA	ZNF8	516	P17098
HAGNKPIKDQLGSSF	ZNF611	146	Q8N823
SGDSLELRKNHKNGP	TASOR2	1231	Q5VWN6
HAGNKPIKNELGSSF	ZNF701	196	Q9NV72
RHAGNKPIKDQLGSS	ZNF600	76	Q6ZNG1
TKGSEDSPPKHAGNN	PTDSS1	436	P48651
KANGTHPKTISRIGS	PSD3	756	Q9NYI0
KPTSATKSDSNLGGH	ZNF638	621	Q14966
DHSKKNIGNGIISSP	USP36	451	Q9P275
RQAKGHKSGQPLGHS	ULK4	321	Q96C45
GPQSSKGSKQSIHDS	WDR64	736	B1ANS9
HGSPISRKNSKDNSD	ZNF391	81	Q9UJN7
SAKAENDKHLSVGPG	KIAA1522	21	Q9P206
NHLGGSLDRASQGPK	N4BP3	216	O15049